News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
5,168 Results
Type
Article (436)
Company Profile (3)
Press Release (4729)
Section
Business (1635)
Career Advice (5)
Deals (218)
Drug Delivery (1)
Drug Development (766)
Employer Resources (1)
FDA (56)
Job Trends (136)
News (2508)
Policy (132)
Tag
Academia (23)
Accelerated approval (1)
Alliances (432)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (9)
Approvals (55)
Artificial intelligence (4)
Autoimmune disease (6)
Automation (1)
Bankruptcy (1)
Best Places to Work (108)
Biosimilars (1)
Biotechnology (3)
Brain cancer (1)
Breast cancer (7)
Cancer (93)
Cardiovascular disease (3)
Career advice (5)
CAR-T (17)
Cell therapy (72)
Clinical research (576)
Collaboration (44)
Compensation (2)
COVID-19 (25)
C-suite (15)
Data (88)
Diabetes (5)
Diagnostics (19)
Diversity (1)
Drug discovery (2)
Duchenne muscular dystrophy (1)
Earnings (576)
Employer resources (2)
Events (1035)
Executive appointments (14)
FDA (74)
Fibrodysplasia Ossificans Progressiva (1)
Funding (19)
Gene editing (3)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (21)
Guidances (3)
Healthcare (276)
HIV (1)
Immunology and inflammation (9)
Immuno-oncology (1)
Indications (2)
Infectious disease (25)
Inflammatory bowel disease (1)
Intellectual property (2)
IPO (128)
Job creations (27)
Job search strategy (3)
JPM (1)
Layoffs (7)
Leadership (1)
Legal (26)
Liver cancer (3)
Lung cancer (2)
Lymphoma (4)
Management (1)
Manufacturing (10)
MASH (2)
Medical device (23)
Medtech (23)
Mergers & acquisitions (105)
Metabolic disorders (7)
Multiple sclerosis (4)
Neuroscience (9)
NextGen: Class of 2026 (58)
Non-profit (17)
Opinion (2)
Ovarian cancer (1)
Pancreatic cancer (4)
Parkinson's disease (1)
Patents (8)
Patient recruitment (6)
People (588)
Pharmaceutical (1)
Phase 1 (385)
Phase 2 (264)
Phase 3 (94)
Pipeline (63)
Policy (1)
Postmarket research (3)
Preclinical (160)
Press Release (3)
Prostate cancer (1)
Radiopharmaceuticals (2)
Rare diseases (9)
Real estate (43)
Recruiting (1)
Regulatory (114)
Reports (3)
Research institute (33)
Series A (3)
Series B (1)
Sickle cell disease (2)
Startups (46)
Vaccines (6)
Date
Last 7 days (6)
Last 30 days (28)
Last 365 days (313)
2026 (32)
2025 (310)
2024 (458)
2023 (464)
2022 (677)
2021 (639)
2020 (474)
2019 (360)
2018 (310)
2017 (251)
2016 (246)
2015 (258)
2014 (132)
2013 (67)
2012 (81)
2011 (76)
2010 (49)
Location
Africa (4)
Alabama (1)
Asia (292)
Australia (19)
California (76)
Canada (17)
China (26)
Colorado (1)
Connecticut (2)
Europe (1113)
Florida (2)
Illinois (4)
Japan (4)
Maryland (34)
Massachusetts (122)
Michigan (1)
Nevada (1)
New Hampshire (4)
New Jersey (17)
New York (30)
North Carolina (5)
Northern California (44)
Pennsylvania (55)
South America (2)
Southern California (16)
Texas (40)
United States (391)
Utah (1)
Washington State (35)
5,168 Results for "lion tcr".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
September 15, 2025
·
3 min read
Business
JPM26: KalVista’s HAE Win Is a ‘Tale of Two Markets’
After winning a surprise approval for its hereditary angioedema drug Ekterly, KalVista is confident the oral offering will capture the lion’s share of the market for on-demand use.
January 21, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
Lion TCR’s Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
February 12, 2025
·
5 min read
Business
MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR’s TCR-T Cell Pipeline
MaxCyte, Inc. today announced the signing of a strategic platform license (SPL).
January 3, 2024
·
4 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
·
4 min read
Press Releases
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
November 17, 2025
·
8 min read
Press Releases
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
December 12, 2025
·
3 min read
Press Releases
Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer
December 8, 2025
·
3 min read
Press Releases
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
November 13, 2025
·
2 min read
Press Releases
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 14, 2025
·
2 min read
1 of 517
Next
